Mutation in Staphylococcus aureus that supports gain of function in susceptibility both to hypochlorous acid and to

Athmane Teghament1, Katrin Schilcher2,3, Jeffery S Kavanaugh2

  • 1Inflammation Program and Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 523 Eckstein Medical Research Building, 431 Newton Road, Iowa City, IA 52242, United States.

PubMed

Insights

Staphylococcus aureus resistance to human neutrophil killing involves the MazF protein. Deleting mazF enhances bacterial survival against hypochlorous acid (HOCl) and within immune cells.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Human neutrophils (PMN) utilize myeloperoxidase (MPO) and hydrogen peroxide (H2O2) to generate hypochlorous acid (HOCl), a potent antimicrobial agent.
  • Despite HOCl's efficacy, some Staphylococcus aureus strains survive within PMN, contributing to disease pathogenesis.

Purpose of the Study:

  • To identify factors contributing to Staphylococcus aureus resistance against PMN-mediated oxidative killing.
  • To investigate the role of the mazF gene in S. aureus susceptibility to hypochlorous acid (HOCl).

Main Methods:

  • Screening the Nebraska Transposon Mutant Library (NTML) of USA300 MRSA for mutants with altered HOCl resistance.
  • Assessing mutant survival after challenge with reagent HOCl and within human PMN.
  • Complementation studies using a wild-type mazF gene to confirm the genetic basis of observed phenotypes.

Main Results:

  • A mutant with a deletion in the mazF gene exhibited increased survival against reagent HOCl compared to the parental strain.
  • The mazF deletion mutant demonstrated enhanced resistance to killing by human PMN.
  • Complementation of the mazF deletion mutant with a wild-type gene restored susceptibility to HOCl and PMN killing.

Conclusions:

  • MazF plays a significant role in Staphylococcus aureus susceptibility to HOCl-mediated damage and killing by human neutrophils.
  • Absence of MazF enhances bacterial resistance and/or repair mechanisms against sublethal damage induced by HOCl or PMN antimicrobial components.
  • Targeting MazF could represent a novel strategy to potentiate S. aureus killing by the host immune system.